WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 9'7501 Infant (under 12 months) mortality rate: 92
GDP / capita (US$): 14'3741 Child (under 5 years) mortality rate: 102

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 4'808  4'758  4'706  4'654  4'600  3'925  3'096  2'389 
Births 70  70  71  71  72  76  83  71 
Surviving infants 69  70  70  70  71  75  81  69 
Pop. less than 5 years 350  354  359  364  365  394  400  320 
Pop. less than 15 years 1'073  1'080  1'090  1'101  1'111  1'207  1'088  882 
Female 15-49 years 1'279  1'272  1'264  1'255  1'244  1'039  787  601 

Number of reported cases

(Click for retrospective incidence data for Costa Rica)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  76  1'000 
Mumps
ChartChart
  30  419 
Pertussis
ChartChart
  20  31  58  130  79  23  75  960 
Polio*
ChartChart
 
Rubella
ChartChart
  86 
Rubella (CRS)
ChartChart
  46 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  17 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Costa Rica)
Vaccine year result method % card seen                                                
BCG 2010  100  MICS   94  83  80  79  78  78  92  92  80 
DTP1 2010  99  MICS   94  93  91  94  92  87  90 
DTP3 2010  94  MICS   94  92  91  95  91  85  88  95  86 
DTP4          80 
IPV1          93  91 
HepB_BD          89  90 
HepB3 2010  93  MICS   94  92  91  94  91  84  89 
Hib3 2010  92  MICS   94  92  91  95  90  81  92 
JapEnc         
MCV1          93  95  91  90  83  82  90  60 
MCV2          90  90  92  95  80 
PCV1          92  95 
PCV3 2010  93  MICS   94  83  89  68 
Pol3 2010  95  MICS   94  92  91  95  90  82  80  95  86 
Rota1         
RotaC         
Rubella1          93  95  91  90  83 
TT2plus 2010  MICS   94  77 
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Costa Rica)
BCG
ChartChart
  83  80  79  78  78  92  92  80 
DTP1
ChartChart
  93  91  98  92  87  90  98  95 
DTP3
ChartChart
  92  91  95  91  85  88  95  86 
HepB3
ChartChart
  92  91  94  91  84  89 
HepB_BD
ChartChart
  89  89  90  90  88 
Hib3
ChartChart
  92  91  95  90  81  92 
MCV1
ChartChart
  93  95  91  90  83  82  90  60 
MCV2
ChartChart
  90  90  92  95  80 
PCV3
ChartChart
  94  83  94  89  68 
Pol3
ChartChart
  92  91  95  90  82  80  95  86 
RCV1
ChartChart
  93  95  91  90  83  82  90 
RotaC
ChartChart
 

Number of districts in the country 81  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibIPV 2, 4, 6, 15 months; Yes
DTaPIPV 4 years; Yes
HepB_Adult st contact; +1, +6 months; Yes risk groups
HepB_Pediatric birth; 2, 6 months; Yes
MMR 15 months; 7 years; Yes
Pneumo_conj 2, 4, 15 months; Yes
Pneumo_ps >=60 years; Yes
Td 10 years; Yes
Tdap Yes CBAW
Varicella 15 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  No  No  No  No  No 
What years does the MYP cover? number 2015-2020  2015-2020        2'011   
Nº of districts with microplans that include activities to raise immunization coverage number 103  103   

System performance

Total Nº districts in country number 81  81  81  81  81  81  81 
Nº districts with DTP3 coverage >=80% number 72  77  69  54  70  68 
% of districts with DTP3 coverage >=80% From 0 to 100% 89  95  85  67  86  84 
Nº districts with measles (MCV1) coverage >=95% number 54  37  37  23  33  29 
% of districts with MCV1 coverage >=95% From 0 to 100% 67  46  46  28  41  36 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND   No  No    Yes  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR   No  Yes    Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%   100  100  100  98  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  No  Yes  Yes   

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.